Con­nect Bio­phar­ma snags $115 mil­lion in Se­ries C to de­vel­op ar­se­nal of im­mune mod­u­la­tors

Zheng Wei and William Pan met in a mol­e­c­u­lar bi­ol­o­gy study group in col­lege in Guangzhou, Chi­na.

In the fol­low­ing decades, the duo trans­formed from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.